Rheumatology

Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation

Pain Catastrophizing Decreases in Rheumatoid Arthritis After DMARD Initiation

By

Pain catastrophizing decreases over time in patients with RA who respond to DMARD treatment.

Exploring the Clinical Implications of Cannabinoid Use in Rheumatoid Arthritis

Exploring the Clinical Implications of Cannabinoid Use in Rheumatoid Arthritis

By

Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.

DAS28 Patient-Reported Components Identify Fibromyalgia in Rheumatoid Arthritis

DAS28 Patient-Reported Components Identify Fibromyalgia in Rheumatoid Arthritis

By

The assessment of patient-reported components of the DAS28 can be a useful way to identify patients with fibromyalgic RA.

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

Widespread Pain Common, Linked to Worse Patient-Reported Disease Activity in PsA

By

Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.

Multiple Factors to Consider When Selecting NSAID for Arthritis

Multiple Factors to Consider When Selecting NSAID for Arthritis

Factors to be considered when choosing the correct nonsteroidal anti-inflammatory drug (NSAID) for arthritis include effectiveness, concurrent health conditions, and frequency of use.

Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis

Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis

By

The percentage of patients with septic arthritis related to opioid or injection drug use was found to have increased from 2000 to 2013.

Efficacy, Safety of OnabotulinumtoxinA Assessed for Knee OA Treatment

Efficacy, Safety of OnabotulinumtoxinA Assessed for Knee OA Treatment

By

Investigators sought to evaluate intra-articular onabotulinumtoxinA 400 U and 200 U in reducing symptoms of knee OA in patients with nociceptive pain.

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

Consensi Approved to Treat Hypertension and Osteoarthritis Pain

By

Consensi combines amlodipine besylate, a calcium-channel blocker (CCB), and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID).

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.

Illness Perceptions Mediate Back Pain, Quality of Life in Early Axial Spondyloarthritis

Illness Perceptions Mediate Back Pain, Quality of Life in Early Axial Spondyloarthritis

By

Illness perceptions are important in the relationship between back pain and health-related quality of life in patients suspected of axial spondyloarthritis.

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

By

Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

By

In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.

Influence of Psychosocial, Sociodemographic Factors on Knee Osteoarthritis-Associated Pain

Influence of Psychosocial, Sociodemographic Factors on Knee Osteoarthritis-Associated Pain

By

A set of psychosocial and sociodemographic factors may be associated with pain levels in patients with knee osteoarthritis.

Zilretta Benefits 'Real-World' Patients With Knee OA, Says Study

Zilretta Benefits 'Real-World' Patients With Knee OA, Says Study

By

Patients who received a repeat Zilretta injection experienced a 64% improvement in Western Ontario and McMaster Universities Arthritis Index (WOMAC)-A (pain), a 66% improvement in WOMAC-B (stiffness), a 64% improvement on WOMAC-C (function), and improvement represented by a doubling of the KOOS Quality of Life subscale score by Week 4.

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

By

Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

By

Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.

No Increased Risk of SLE With Current Use of Statin Therapy

No Increased Risk of SLE With Current Use of Statin Therapy

By

No association was found between current statin use and the risk of developing systemic lupus erythematosus.

SLE Disease Flares Associated With Childhood Diffuse Alveolar Hemorrhage

SLE Disease Flares Associated With Childhood Diffuse Alveolar Hemorrhage

By

Diffuse alveolar hemorrhage in childhood-onset SLE is associated with serious disease flares, and is complicated by sepsis and high mortality rate.

New SLE Candidate Criteria

New SLE Candidate Criteria

By

Researchers have created a set of 21 candidate criteria for systemic lupus erythematosus as apart of a multiphase development of a set of criteria for the disease.

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

By

The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.

Disease Activity Biomarker in Pediatric SLE

Disease Activity Biomarker in Pediatric SLE

By

Fractional exhaled nitric oxide monitoring may provide a potential biomarker of disease activity and signify the emergency of pulmonary involvement in children with SLE.

Certain Osteoporotic Drugs Effective in Preventing Secondary Vertebral Fractures

Certain Osteoporotic Drugs Effective in Preventing Secondary Vertebral Fractures

By

Clinicians who treat osteoporotic fractures should prescribe anti-osteoporotic drugs to prevent secondary vertebral and non-vertebral fractures.

Synovitis Detected by Ultrasound in Psoriatic Arthritis in Remission

Synovitis Detected by Ultrasound in Psoriatic Arthritis in Remission

By

Underlying synovitis and enthesitis may go undetected in clinical findings, but can be detected by power Doppler ultrasounds.

Association Between Low Levels of Blimp-1 Protein, Lupus

Association Between Low Levels of Blimp-1 Protein, Lupus

Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.

Biomarkers of Increased PAH Risk Identified in Patients With SLE

Biomarkers of Increased PAH Risk Identified in Patients With SLE

By

The risk for death associated with SLE remains high for patients with SLE-associated PAH and researchers have identified the biomarkers that may lead to early detection.

Early CVD Detection in Patients With RA: Expert Insight

Early CVD Detection in Patients With RA: Expert Insight

By

Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

By

A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.

Fish Consumption May Reduce RA Symptoms

Fish Consumption May Reduce RA Symptoms

Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis.

Lesinurad Plus Febuxostat for Tophaceous Gout

Lesinurad Plus Febuxostat for Tophaceous Gout

In patients with tophaceous gout, combination therapy of lesinurad plus febuxostat is more effective at reducing serum urate levels than febuxostat monotherapy.

Risk Factor for Osteonecrosis in Patients With SLE

Risk Factor for Osteonecrosis in Patients With SLE

By

Cumulative steroid dosage is a risk factor for the development of osteonecrosis, which is the most frequent type of damage in lupus patients.

Sign Up for Free e-Newsletters